Business Description
Krka DD
ISIN : SI0031102120
Total Employee Number:
13,204Compare
Compare
Traded in other countries / regions
KRKG.Slovenia0HLK.UKKRK.PolandKN8.GermanyKRKG.Austria IPO Date
2025-04-09Description
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 41.01 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.03 | |||||
Interest Coverage | 69.95 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 9.69 | |||||
Beneish M-Score | -2.49 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 3.9 | |||||
3-Year EPS without NRI Growth Rate | 5.2 | |||||
3-Year FCF Growth Rate | 5.5 | |||||
3-Year Book Growth Rate | 4.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 5.55 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.84 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.35 | |||||
9-Day RSI | 47.76 | |||||
14-Day RSI | 49.11 | |||||
3-1 Month Momentum % | 7.9 | |||||
6-1 Month Momentum % | 23.57 | |||||
12-1 Month Momentum % | 35.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.05 | |||||
Quick Ratio | 2.9 | |||||
Cash Ratio | 1.43 | |||||
Days Inventory | 258.61 | |||||
Days Sales Outstanding | 110.45 | |||||
Days Payable | 62.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.21 | |||||
Dividend Payout Ratio | 0.69 | |||||
3-Year Dividend Growth Rate | 13.6 | |||||
Forward Dividend Yield % | 3.54 | |||||
5-Year Yield-on-Cost % | 6.29 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 3.85 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.55 | |||||
Operating Margin % | 23.68 | |||||
Net Margin % | 17.85 | |||||
EBITDA Margin % | 27.16 | |||||
FCF Margin % | 16.91 | |||||
OCF Margin % | 21.68 | |||||
ROE % | 15.5 | |||||
ROA % | 12.06 | |||||
ROIC % | 18.84 | |||||
3-Year ROIIC % | 27.84 | |||||
ROC (Joel Greenblatt) % | 29.26 | |||||
ROCE % | 18.25 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.88 | |||||
Forward PE Ratio | 19.63 | |||||
PE Ratio without NRI | 21.97 | |||||
Shiller PE Ratio | 25.14 | |||||
Price-to-Owner-Earnings | 19.09 | |||||
PEG Ratio | 4.39 | |||||
PS Ratio | 3.89 | |||||
PB Ratio | 3.21 | |||||
Price-to-Tangible-Book | 3.37 | |||||
Price-to-Free-Cash-Flow | 22.87 | |||||
Price-to-Operating-Cash-Flow | 17.86 | |||||
EV-to-EBIT | 15.26 | |||||
EV-to-EBITDA | 12.72 | |||||
EV-to-Revenue | 3.45 | |||||
EV-to-FCF | 20.42 | |||||
Price-to-GF-Value | 1.73 | |||||
Price-to-Projected-FCF | 1.69 | |||||
Price-to-DCF (Earnings Based) | 0.96 | |||||
Price-to-DCF (FCF Based) | 1.33 | |||||
Price-to-Median-PS-Value | 2.16 | |||||
Price-to-Graham-Number | 1.81 | |||||
| Price-to-Net-Current-Asset-Value | 5.61 | |||||
| Price-to-Net-Cash | 208.94 | |||||
Earnings Yield (Greenblatt) % | 6.55 | |||||
FCF Yield % | 4.46 | |||||
Forward Rate of Return (Yacktman) % | 7.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Krka DD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,084.685 | ||
| EPS (TTM) (€) | 11.93 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 17.98 | ||
| 14-Day RSI | 49.11 | ||
| 14-Day ATR (€) | 8.64798 | ||
| 20-Day SMA (€) | 260.65 | ||
| 12-1 Month Momentum % | 35.16 | ||
| 52-Week Range (€) | 184 - 273 | ||
| Shares Outstanding (Mil) | 30.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Krka DD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Krka DD Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 9.100000 Cash Dividend | 2026-07-21 | In 8 days | ||
| EUR 8.250000 Cash Dividend | 2025-07-22 | 198.50 (+1.79%) |
Show
Entries
Krka DD Frequently Asked Questions
What is Krka DD(FRA:KN8)'s stock price today?
The current price of FRA:KN8 is €257.00. The 52 week high of FRA:KN8 is €273.00 and 52 week low is €184.00.
When is next earnings date of Krka DD(FRA:KN8)?
The next earnings date of Krka DD(FRA:KN8) is .
Does Krka DD(FRA:KN8) pay dividends? If so, how much?
The Dividend Yield %  of Krka DD(FRA:KN8) is 3.21% (As of Today), Highest Dividend Payout Ratio of Krka DD(FRA:KN8) was 0.79. The lowest was 0.4. And the median was 0.56. The  Forward Dividend Yield % of Krka DD(FRA:KN8) is 3.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Krka Extends Use of Calyx Regulatory Information Management System based on Decade of Successful Experience | 2022-08-02 |
Articles on Krka DD
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers